- Home
- NSA vs XENE Comparison
NSA vs XENE Comparison
Compare NSA & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSA
- XENE
- Stock Information
- Founded
- NSA 2013
- XENE 1996
- Country
- NSA United States
- XENE Canada
- Employees
- NSA N/A
- XENE N/A
- Industry
- NSA Real Estate Investment Trusts
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- NSA Real Estate
- XENE Health Care
- Exchange
- NSA Nasdaq
- XENE Nasdaq
- Market Cap
- NSA 3.4B
- XENE 3.0B
- IPO Year
- NSA 2015
- XENE 2014
- Fundamental
- Price
- NSA $44.18
- XENE $40.14
- Analyst Decision
- NSA Hold
- XENE Strong Buy
- Analyst Count
- NSA 9
- XENE 10
- Target Price
- NSA $43.31
- XENE $57.30
- AVG Volume (30 Days)
- NSA 469.1K
- XENE 397.0K
- Earning Date
- NSA 10-30-2024
- XENE 11-12-2024
- Dividend Yield
- NSA 5.01%
- XENE N/A
- EPS Growth
- NSA 71.81
- XENE N/A
- EPS
- NSA 1.83
- XENE N/A
- Revenue
- NSA $786,922,000.00
- XENE N/A
- Revenue This Year
- NSA N/A
- XENE N/A
- Revenue Next Year
- NSA $1.63
- XENE $1,600.08
- P/E Ratio
- NSA $24.46
- XENE N/A
- Revenue Growth
- NSA N/A
- XENE N/A
- 52 Week Low
- NSA $32.42
- XENE $28.20
- 52 Week High
- NSA $49.44
- XENE $50.99
- Technical
- Relative Strength Index (RSI)
- NSA 54.29
- XENE 39.82
- Support Level
- NSA $43.11
- XENE $37.34
- Resistance Level
- NSA $44.26
- XENE $44.61
- Average True Range (ATR)
- NSA 1.07
- XENE 1.71
- MACD
- NSA 0.28
- XENE -0.58
- Stochastic Oscillator
- NSA 82.97
- XENE 22.98
About NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, Northwest and Move It brands.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.